Menopause can affect far more than menstrual periods. Falling and fluctuating estrogen levels can bring hot flashes, night sweats, disrupted sleep, anxiety, mood changes, joint discomfort, headaches, vaginal dryness, painful sex and changes in sexual desire. For some women these symptoms are manageable; for others they interfere substantially with work, relationships and quality of life. As medical and recreational cannabis have become more accessible, an increasing number of women have begun using marijuana, CBD products and cannabinoid oils in an attempt to manage these symptoms.
The popularity of cannabis during menopause has grown considerably faster than the scientific evidence supporting it. Surveys from Harvard Medical School, McLean Hospital and the University of Alberta show that many perimenopausal and postmenopausal women already use cannabis for symptoms such as poor sleep, anxiety and muscle or joint pain. Yet randomized clinical trials directly testing marijuana as a menopause treatment remain remarkably scarce. The Menopause Society’s evidence-based guidance currently does not recommend cannabinoids for vasomotor symptoms such as hot flashes, while hormone therapy and several nonhormonal prescription treatments have much stronger evidence. Medical cannabis may still affect certain symptoms, particularly sleep or pain in selected patients, but it should not be presented as a proven comprehensive treatment for menopause.
Why Women Are Using Cannabis During Menopause
One of the clearest findings in current research is not that cannabis definitely works, but that large numbers of women believe it helps. A Harvard Medical School and McLean Hospital survey involving 258 perimenopausal and postmenopausal participants found that 78.7% reported using medical cannabis specifically for menopause-related symptoms. Sleep problems were the most common target, reported by 67.4%, followed by mood and anxiety symptoms at 46.1%. Smoking and edible cannabis were the most frequently reported methods of use.
A much larger University of Alberta survey included 1,485 women aged 35 and older. About one-third were current cannabis users, and more than three-quarters of those users reported using cannabis for medical reasons. Sleep was again the leading reason at 65%, followed by anxiety at 45% and muscle or joint aches at 33%. About 74% of current users believed cannabis helped their symptoms. These findings are useful because they show what women are actually doing, but surveys cannot establish effectiveness. People choosing cannabis may differ from nonusers in symptom severity, expectations, other health conditions and previous cannabis experience. Self-reported improvement is therefore a reason to conduct clinical trials—not a substitute for them.
Can Marijuana Help Hot Flashes and Night Sweats?
Hot flashes and night sweats, collectively called vasomotor symptoms, are among the hallmark symptoms of the menopause transition. Cannabis is sometimes promoted for hot flashes because the endocannabinoid system participates in temperature regulation, stress responses and other processes that could theoretically overlap with vasomotor symptoms. Some women also report subjectively feeling fewer or less disruptive hot flashes after using marijuana. The problem is that convincing randomized clinical evidence has not demonstrated that benefit.
A University of Toronto systematic review searched hundreds of publications examining cannabis in perimenopausal and postmenopausal women but found only three studies meeting its criteria. Those studies provided little meaningful evidence that marijuana improved hot flashes, insomnia, mood or sexual symptoms. The reviewers concluded that cannabis was being used for menopause despite a major lack of evidence supporting its effectiveness.
The Menopause Society reached an even clearer conclusion in its 2023 position statement on nonhormonal treatment of vasomotor symptoms. After reviewing available therapies, the expert panel listed cannabinoids among treatments that are not recommended, based on limited or inconsistent evidence. By comparison, cognitive behavioral therapy, clinical hypnosis, certain SSRIs and SNRIs, gabapentin and the neurokinin-3 receptor antagonist fezolinetant received evidence-based recommendations. Hormone therapy continues to be considered the most effective treatment for bothersome hot flashes and night sweats in appropriate candidates.
Cannabis for Menopause-Related Sleep Problems
Sleep may be the menopause symptom for which cannabis use is most understandable from a practical standpoint. Night sweats can repeatedly wake someone from sleep, while anxiety, pain and changing circadian patterns may make falling asleep more difficult. THC can cause sedation, and some users report that marijuana shortens the time needed to fall asleep. This helps explain why sleep consistently appears as the leading menopause-related reason for cannabis use in both Harvard/McLean and University of Alberta surveys.
The wider sleep literature is less definitive. The National Center for Complementary and Integrative Health notes that studies of cannabinoids in people with chronic pain, multiple sclerosis and other illnesses have sometimes found improvements in sleep quality or sleep disturbance. However, researchers cannot always determine whether cannabis directly improved sleep or whether people simply slept better because pain or another underlying symptom improved. Evidence for cannabinoids as a treatment for primary sleep problems remains uncertain.
THC can also create a tradeoff between nighttime sedation and next-day performance. Higher doses may cause grogginess, impaired attention or dizziness, while frequent use may lead to tolerance. Abrupt cessation after heavy use can itself disturb sleep. Someone who occasionally uses a very low THC dose at night is therefore in a different situation from someone who needs escalating doses every evening to sleep. Cannabis may help certain individuals subjectively, but it does not yet have the evidence base of established menopause and insomnia treatments.
Anxiety, Mood Changes and Irritability
The menopause transition can coincide with anxiety, irritability and changes in mood, especially during perimenopause when hormone concentrations may fluctuate substantially. Cannabis users commonly describe THC or CBD as relaxing, and mood or anxiety was the second most common menopause-related reason for medical cannabis use in the Harvard/McLean study. A more recent national survey from the same research group found that women with greater menopause symptom burden were more likely to report specifically medical rather than recreational cannabis use.
Yet cannabis does not consistently reduce anxiety. THC can produce markedly different effects depending on dose and individual sensitivity. The CDC notes that cannabis can cause anxiety, paranoia and disorientation, and frequent use is associated with several psychiatric conditions, although association does not establish that cannabis caused those conditions. A woman who feels calmer after a small amount of THC may experience panic, racing thoughts or palpitations after consuming a stronger edible or concentrate.
This matters particularly for women already taking antidepressants or anti-anxiety medications. Cannabis can add sedation or dizziness, and concentrated CBD can alter the metabolism of some prescription drugs. Persistent or severe depression, panic symptoms or major changes in functioning deserve appropriate clinical assessment rather than treatment solely with cannabis.
Joint Pain, Body Aches and Headaches
Muscle and joint discomfort frequently becomes more noticeable during midlife, although not every ache occurring around menopause is caused directly by estrogen decline. Cannabis may have a somewhat stronger scientific foundation for chronic pain in general than it does for hot flashes. NCCIH concludes that certain cannabinoid products may provide modest short-term benefit for some chronic pain conditions, particularly neuropathic pain, while also increasing side effects such as dizziness and sleepiness.
That evidence should not be stretched too far. Studies showing benefit for neuropathic or other chronic pain do not prove that marijuana specifically treats menopause-related joint pain. The University of Alberta survey found that 33% of current cannabis users used it for muscle and joint achiness, but again, that was self-reported use rather than a randomized comparison with placebo.
For someone whose most troublesome menopause symptom is chronic pain rather than hot flashes, cannabinoids may warrant a different conversation than they would for someone seeking treatment exclusively for vasomotor symptoms. The potential benefit needs to be weighed against impairment, dizziness, medication interactions and the underlying cause of the pain.
Vaginal Dryness, Painful Sex and Sexual Symptoms
The decline in estrogen after menopause can produce genitourinary syndrome of menopause, which includes vaginal dryness, burning, irritation, urinary symptoms and pain during sexual activity. Cannabis-related lubricants, CBD creams and suppositories are increasingly marketed for sexual wellness, but clinical evidence supporting these products remains weak. There is currently no established cannabinoid treatment shown to reverse the tissue changes responsible for genitourinary syndrome.
Evidence-based therapies are much better defined. The Menopause Society’s position statement on genitourinary syndrome identifies vaginal moisturizers and lubricants for milder symptoms and therapies including low-dose vaginal estrogen, vaginal DHEA, systemic hormone therapy and ospemifene when appropriate. A newer multidisciplinary guideline similarly bases treatment on the estrogen-related changes occurring within the genitourinary tract.
Cannabis may indirectly influence sexual experiences by reducing anxiety, pain or inhibition for some users, while excessive THC may interfere with concentration or sexual functioning in others. There is not enough evidence to recommend a particular THC ratio, topical product or vaginal cannabis preparation for menopause-related sexual symptoms. Persistent painful intercourse or vaginal irritation should also be evaluated because infections, dermatologic disorders and other conditions can resemble menopause-related symptoms.
CBD Is Not Automatically the Safer Menopause Option
CBD is often marketed to women who want menopause relief without getting high. Because CBD is not strongly intoxicating, it avoids some of the impairment associated with THC. That does not make CBD medically inactive. FDA warns that CBD can cause liver injury, drowsiness, gastrointestinal symptoms and clinically significant drug interactions. CBD can change the way other medications are metabolized, potentially raising or lowering their concentrations.
This becomes especially relevant during menopause because many women simultaneously use medications for blood pressure, cholesterol, depression, anxiety, insomnia, thyroid disease or chronic pain. Some may also be using hormone therapy. There is not enough direct evidence to define a universal cannabis–menopausal hormone therapy interaction, but the broader ability of CBD to alter drug metabolism means an individual’s complete medication list should be reviewed.
FDA has also not approved over-the-counter CBD products for menopause symptoms. Aside from the prescription CBD medicine Epidiolex for specific seizure disorders, commercial CBD oils and gummies have not been evaluated as approved medications for hot flashes, sleep disturbance or other menopause complaints.
THC Risks May Become More Relevant in Midlife
THC can impair coordination, reaction time, memory and judgment. CDC warns that cannabis can slow reaction time and decision-making and interfere with coordination. This can be especially relevant when THC is combined with prescription sleep medications, benzodiazepines, sedating antidepressants, gabapentin, opioids or alcohol.
Cardiovascular health also deserves consideration as women move through midlife. The CDC notes that cannabis can acutely increase heart rate and blood pressure and that research continues into possible associations with cardiovascular and vascular disease. Smoking marijuana additionally exposes the lungs and cardiovascular system to combustion products similar to some of those present in tobacco smoke.
Edibles avoid smoke exposure but introduce their own problem: delayed onset. Effects may take up to approximately two hours to become apparent, making accidental redosing more likely. Someone expecting immediate relief from a nighttime edible may take another dose too soon and experience much greater intoxication later.
Where Medical Marijuana Fits Compared With Proven Menopause Treatments
For hot flashes and night sweats, medical cannabis remains well behind established therapies. The Menopause Society states that hormone therapy remains the most effective treatment for vasomotor symptoms and generally has the most favorable benefit-risk profile for appropriately selected symptomatic women who are younger than 60 or within about 10 years of menopause onset. Treatment still needs to be individualized because medical history, cardiovascular risk, cancer history and other factors can change whether hormone therapy is appropriate.
Women who cannot or do not want to use hormone therapy also have evidence-based nonhormonal options. The Menopause Society recommends several treatments, including certain SSRIs and SNRIs, gabapentin, fezolinetant, cognitive behavioral therapy and clinical hypnosis. Cannabinoids were specifically placed in the not-recommended category for vasomotor symptoms because the evidence was insufficient or inconsistent.
That does not mean every woman using marijuana during menopause is receiving no benefit. Cannabis may improve a secondary symptom such as chronic pain or may subjectively help someone sleep. The distinction is that these individual experiences have not yet translated into evidence showing that marijuana reliably treats the underlying menopause symptom complex.
The Bottom Line
Medical marijuana is already widely used during perimenopause and after menopause, particularly for sleep problems, anxiety and body aches. Surveys from Harvard/McLean and the University of Alberta show that many users believe cannabis improves their symptoms. These findings make cannabinoid therapy an important research topic and demonstrate that clinicians should ask about cannabis use without stigma. They do not establish cannabis as an evidence-based menopause treatment.
For the symptom most closely associated with menopause—hot flashes and night sweats—the current guidance is clear: cannabinoids are not recommended on the basis of existing evidence, while hormone therapy and several nonhormonal treatments have considerably stronger clinical support. Cannabis may still have a role for selected women dealing with overlapping pain or sleep problems, but THC dose, CBD dose, route of administration, cardiovascular health, mental-health history and prescription medications all matter.
The most useful way to think about cannabis during menopause is therefore not as a replacement for established menopause care but as another biologically active treatment whose potential benefits vary by symptom. Women considering medical marijuana should know exactly which problem they are trying to improve, monitor whether the benefit is meaningful, and avoid assuming that feeling better after cannabis means it is correcting the hormonal changes responsible for menopause. As controlled trials specifically involving menopausal women begin to catch up with widespread real-world use, recommendations may become more precise. For now, the enthusiasm surrounding cannabis is considerably stronger than the clinical evidence.
